Research

David Hodes has written for many cannabis publications, and organized or moderated sessions at national and international cannabis trade shows. He was voted the 2018 Journalist of the Year by Americans for Safe Access, the world’s largest medical cannabis advocacy organization.

Articles

Better seed genetics, power-free tunable lighting, and other new scientific discoveries are making headway in what has become an ag-tech leading industry.

Cultivation Breakthroughs  for a More Uniform Plant Are Coming

This study presents bioassays for CBD, which can be used to assess the neurotrophic bioactivity of CBD formulations.

Measuring Cannabidiol Bioactivity: Neuronal Cell Survival and Neurite Outgrowth

Josh Crossney is the columnist and editor of “Cannabis Crossroads” and a contributing editor to 

 magazine. Crossney is also the president and CEO of Cannabis Science Conference. Direct correspondence to:


David Heldreth, Founder and CEO of Panacea Plant Sciences, discusses the rise in interest in psychedelic medicine and more.

A Closer Look at the Rise of Psychedelic Medicine and Panacea Plant Sciences

This study offers guidance to establishing meaningful quality standards for the commercialization of cannabis and cannabis-related products.

Microbiological Implications  of Commercial Cannabis in Northern California:  A Survey of Bacterial  and Fungal Contamination

Here we take an in-depth exploration of the structure, function, and variation of cannabinoid receptor 1 (CB1R).

Cannalingo, Part I:  A Guided Tour Through the Influence of Protein Structure and Function  on Cannabinoid Signaling

Dewey Scientific discovers the first powdery mildew resistant gene found in cannabis.

Peer-Reviewed Research Identifies the First Powdery Mildew Resistance Gene in Cannabis 

Cannabis’s biggest antagonist is the stigma that surrounds it. Whole plant medicine has the potential to significantly benefit the pharmaceutical industry by complementing their efforts to bring patients relief from their ailments. Systems dynamics consultant/researcher, Ruth Fisher, PhD, explains how cannabis has the option to flourish but needs to stop having its efforts for growth and research hampered by opinions.

Whole Plant Medicine Is the Future

This technical piece is focused on the separation of the individual enantiomers of each compound mentioned above, as well as the combined separation of the compounds from each other for a fast, reliable quantification.

The Separation of Several Minor Cannabinoids via Chiral HPLC

Dr. Marion McNabb has been conducting surveys related to medical cannabis for about five years and her most recent endeavor is to gauge the knowledge, interest, and understanding of medical cannabis in healthcare professionals. In this interview, she discusses her latest study as well as her background and key insights into the medical cannabis industry.

Research Abounds: How Dr. Marion McNabb is Looking to Take the Medical Cannabis Industry to the Next Level

A systematic literature review to identify and compare analytical methods used for the determination of cannabinoids in different matrices using LC-based systems.